- Home
- EMA vs ASND Comparison
EMA vs ASND Comparison
Compare EMA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMA | ASND |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Canada | Denmark |
| Employees | 7812 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 13.6B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | EMA | ASND |
|---|---|---|
| Price | $53.23 | $227.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $279.50 |
| AVG Volume (30 Days) | 231.2K | ★ 626.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $98.02 |
| Revenue Next Year | $11.18 | $43.13 |
| P/E Ratio | $19.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.90 | $124.06 |
| 52 Week High | $53.91 | $248.60 |
Technical Indicators
Market Signals| Indicator | EMA | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 47.71 |
| Support Level | $47.18 | $190.49 |
| Resistance Level | N/A | $229.94 |
| Average True Range (ATR) | 0.77 | 8.34 |
| MACD | 0.08 | -1.63 |
| Stochastic Oscillator | 80.34 | 18.40 |
Price Performance
Historical ComparisonAbout EMA Emera Incorporated
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.